<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Medical Xpress news tagged with:journal of experimental medicine</title>
            <link>https://medicalxpress.com/</link>
            <language>en-us</language> 
            <description>Medical Xpress internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

                            <item>
                    <title>Novel vaccine approach to human cytomegalovirus found effective</title>
                    <description>An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more effective than previous vaccines developed to prevent infection by the ubiquitous virus.</description>
                    <link>https://medicalxpress.com/news/2013-09-vaccine-approach-human-cytomegalovirus-effective.html</link>
                    <category></category>
                    <pubDate>Wed, 18 Sep 2013 09:20:19 EDT</pubDate>
                    <guid isPermaLink="false">news298714807</guid>
                                    </item>
                            <item>
                    <title>Prospective Alzheimer&#039;s drug builds new brain cell connections</title>
                    <description>Washington State University researchers have developed a new drug candidate that dramatically improves the cognitive function of rats with Alzheimer&#039;s-like mental impairment.</description>
                    <link>https://medicalxpress.com/news/2012-10-prospective-alzheimer-drug-brain-cell.html</link>
                    <category></category>
                    <pubDate>Thu, 11 Oct 2012 04:04:39 EDT</pubDate>
                    <guid isPermaLink="false">news269147063</guid>
                                    </item>
                            <item>
                    <title>PET predicts early response to treatment for head and neck cancer patients</title>
                    <description>Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent. Research published in the October issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) imaging with 3&#039;-deoxy-3&#039;F-18-fluorothymidine (18-F-FLT) during treatment and early follow-up has the potential to predict therapeutic responses and identify patients needing close follow-up to detect persistent or recurring disease.</description>
                    <link>https://medicalxpress.com/news/2012-10-pet-early-response-treatment-neck.html</link>
                    <category></category>
                    <pubDate>Mon, 01 Oct 2012 12:10:03 EDT</pubDate>
                    <guid isPermaLink="false">news268311404</guid>
                                    </item>
                    </channel>
</rss>
